Cardiac muscle patches containing four types of cardiac cells derived from human pluripotent stem cells improve recovery from cardiac injury in mice
Cardiovascular Research · 02.05.2023 · 119 (4) · 1062-1076
DOI: 10.1093/cvr/cvad004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 17.01.2023. Verfasst von Xi Lou und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, School of Medicine and School of Engineering, University of Alabama at Birmingham, 1670 University Boulevard, V…. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Myocardial Infarction, Pluripotent Stem Cells, Heart Injuries. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIBIB NIH HHS, NHLBI NIH HHS, National Institute of Health.
Abstract (Originalsprache)
Aims
We have shown that human cardiac muscle patches (hCMPs) containing three different types of cardiac cells—cardiomyocytes (CMs), smooth muscle cells (SMCs), and endothelial cells (ECs), all of which were differentiated from human pluripotent stem cells (hPSCs)—significantly improved cardiac function, infarct size, and hypertrophy in a pig model of myocardial infarction (MI). However, hPSC-derived CMs (hPSC-CMs) are phenotypically immature, which may lead to arrhythmogenic concerns; thus, since hPSC-derived cardiac fibroblasts (hPSC-CFs) appear to enhance the maturity of hPSC-CMs, we compared hCMPs containing hPSC-CMs, -SMCs, -ECs, and -CFs (4TCC-hCMPs) with a second hCMP construct that lacked hPSC-CFs but was otherwise identical [hCMP containing hPSC-CMs, -AECs, and -SMCs (3TCC-hCMPs)]. Methods and results hCMPs were generated in a fibrin scaffold. MI was induced in severe combined immunodeficiency (SCID) mice through permanent coronary artery (left anterior descending) ligation, followed by treatment with cardiac muscle patches. Animal groups included: MI heart treated with 3TCC-hCMP; with 4TCC-hCMP; MI heart treated with no patch (MI group) and sham group. Cardiac function was evaluated using echocardiography, and cell engraftment rate and infarct size were evaluated histologically at 4 weeks after patch transplantation. The results from experiments in cultured hCMPs demonstrate that the inclusion of cardiac fibroblast in 4TCC-hCMPs had (i) better organized sarcomeres; (ii) abundant structural, metabolic, and ion-channel markers of CM maturation; and (iii) greater conduction velocities (31 ± 3.23 cm/s, P < 0.005) and action-potential durations (APD50 = 365 ms ± 2.649, P < 0.0001; APD = 408 ms ± 2.757, P < 0.0001) than those (velocity and APD time) in 3TCC-hCMPs. Furthermore, 4TCC-hCMPs transplantation resulted in better cardiac function [ejection fraction (EF) = 49.18% ± 0.86, P < 0.05], reduced infarct size (22.72% ± 0.98, P < 0.05), and better engraftment (15.99% ± 1.56, P < 0.05) when compared with 3TCC-hCMPs (EF = 41.55 ± 0.92%, infarct size = 39.23 ± 4.28%, and engraftment = 8.56 ± 1.79%, respectively).
Conclusion
Collectively, these observations suggest that the inclusion of hPSC-CFs during hCMP manufacture promotes hPSC-CM maturation and increases the potency of implanted hCMPs for improving cardiac recovery in mice model of MI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Engineering, School of Medicine and School of Engineering, University of Alabama at Birmingham, 1670 University Boulevard, Volker Hall G094J, Birmingham, AL 35294, USA.
- Morgridge Institute for Research, Madison, WI 53715, USA.
- Division of Cardiovascular Medicine, Department of Medicine, University of Wisconsin-Madison, Madison, WI, USA.
- Department of Cell and Regenerative Biology, University of Wisconsin-Madison, Madison, WI, USA.
- Department of Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
ORCID-Profile: Xi Lou
Förderung
- NIBIB NIH HHS
- NHLBI NIH HHS
- National Institute of Health
Zitieren
APA
Lou, X., Tang, Y., Ye, L., Pretorius, D., Fast, V. G., Kahn-Krell, A. M., Zhang, J., Zhang, J., Qiao, A., Qin, G., Kamp, T., Thomson, J. A., & Zhang, J. (2023). Cardiac muscle patches containing four types of cardiac cells derived from human pluripotent stem cells improve recovery from cardiac injury in mice. Cardiovascular Research, 119(4), 1062-1076. https://doi.org/10.1093/cvr/cvad004
Vancouver
Lou X, Tang Y, Ye L, Pretorius D, Fast VG, Kahn-Krell AM, et al. Cardiac muscle patches containing four types of cardiac cells derived from human pluripotent stem cells improve recovery from cardiac injury in mice. Cardiovascular Research. 2023;119(4):1062-1076. doi:10.1093/cvr/cvad004
BibTeX
@article{Lou2023,
author = {Lou, Xi and Tang, Yawen and Ye, Lei and Pretorius, Danielle and Fast, Vladimir G and Kahn-Krell, Asher M and Zhang, Jue and Zhang, Jianhua and Qiao, Aijun and Qin, Gangjian and Kamp, Timothy and Thomson, James A and Zhang, Jianyi},
title = {Cardiac muscle patches containing four types of cardiac cells derived from human pluripotent stem cells improve recovery from cardiac injury in mice},
journal = {Cardiovascular Research},
year = {2023},
volume = {119},
number = {4},
pages = {1062--1076},
doi = {10.1093/cvr/cvad004}
}
EUVIMED